| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Nov 2025 | 1 Nov 2025 |
| Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve To Consider and take on Record of the Un-Audited Financial results for the half year ended on 30th September 2025. Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended on 30th September, 2025 Unaudited Financial Results for the half year ended on 30th September, 2025 (As Per BSE Announcement Dated on:10.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.